ARCHIVES

FDA Begins To Examine Its Role In Allowing Misleading Consumer Advertising.

This article is from The Cancer Letter archive.

Vol. 33 No. 19 | May 18, 2007

Download PDF Visit The Full Archive

Related Articles

Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies

June 25, 2010

Diet & Nutrition Workshops Planned

March 14, 1975

House Approves Waxman Bill Unanimously; Hatch Introduces His Measure

June 21, 1985

Interactive R01 Scores Vary widely, Result Of separate Review

June 11, 1993

AHCPR Invites Ideas for Outcomes Research

June 7, 1996

Von Eschenbach To Leave FDA Jan. 20, Says He Was “In Love” With The Agency.

December 19, 2008